CRP and lymphopenia: Absence of CHRFAM7A expression in COVID-19 patients was associated with some increased inflammatory biological markers and COVID-19 severity (lymphopenia, elevated CRP, elevated plasma viral load) with extension of the pulmonary lesions and with enhanced expression of genes of the TNF signaling pathway.